High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death.

Paradigms and Technologies
Therapeutic Approaches
Drug Repurposing

Abstract

Human ATAD5 is a biomarker for identifying genotoxic compounds because ATAD5 protein levels increase posttranscriptionally in response to DNA damage. We screened over 4,000 compounds with a cell-based quantitative high-throughput ATAD5-luciferase assay detecting genotoxic compounds. We identified 22 antioxidants, including resveratrol, genistein, and baicalein, that are currently used or investigated for the treatment of cardiovascular disease, type 2 diabetes, osteopenia, osteoporosis, and chronic hepatitis, as well as for antiaging. Treatment of dividing cells with these compounds induced DNA damage and resulted in cell death. Despite their genotoxic effects, resveratrol, genistein, and baicalein did not cause mutagenesis, which is a major side effect of conventional anticancer drugs. Furthermore, resveratrol and genistein killed multidrug-resistant cancer cells. We therefore propose that resveratrol, genistein, and baicalein are attractive candidates for improved chemotherapeutic agents.

Authors

Fox, Jennifer T; Sakamuru, Srilatha; Huang, Ruili; Teneva, Nedelina; Simmons, Steven O; Xia, Menghang; Tice, Raymond R; Austin, Christopher; Myung, Kyungjae;

Keywords

  • Antioxidants/ pharmacology
  • Cell Death/ drug effects
  • Cell Line
  • DNA Damage
  • Drug Resistance, Multiple
  • Drug Resistance, Neoplasm
  • Flavanones/ pharmacology
  • Genistein/ pharmacology
  • Humans
  • Mutagenicity Tests
  • Stilbenes/ pharmacology

External Links